PTJ
CBPO

Paul Tudor Jones’s China Biologic Products Holdings, Inc. CBPO Stock Holding History

Paul Tudor Jones’s Portfolio CBPO Stock Details CBPO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q2 		– Sell
-1,938
Closed -$222K – 2085
2016
Q1 		$222K Buy
1,938
+70
+4% +$8.21K 0.01% 1455
2015
Q4 		$266K Buy
+1,868
New +$216K 0.01% 1285

Other funds holding CBPO

Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
WP
Warburg Pincus New York $187M AUM 34% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
Mirae Asset Global Investments
Mirae Asset Global Investments Seoul, South Korea $67.7B AUM 57.61% 1-Year Est. Return
ICP
Indus Capital Partners New York $29.9M AUM 15.85% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.14% 1-Year Est. Return

Paul Tudor Jones's CBPO Position: Q2 2016 in Review

Paul Tudor Jones sold out of China Biologic Products Holdings, Inc. (CBPO) in Q2 2016, closing a stake of 1,938 shares — an estimated $222K sold.

Paul Tudor Jones first reported a position in CBPO in Q4 2015 and held it in 2 quarters. The position peaked at $266K in Q4 2015. 138 funds tracked by Wall St. Rank hold CBPO as of Q2 2016.

  • Paul Tudor Jones reported no remaining China Biologic Products Holdings, Inc. position as of Q2 2016 after selling out during the quarter.
  • Paul Tudor Jones sold 1,938 China Biologic Products Holdings, Inc. shares in Q2 2016, an estimated $222K.
  • Paul Tudor Jones first reported a position in China Biologic Products Holdings, Inc. in Q4 2015 and held it in 2 quarters.
  • Paul Tudor Jones's China Biologic Products Holdings, Inc. position peaked at $266K in Q4 2015.
  • 138 funds tracked by Wall St. Rank held China Biologic Products Holdings, Inc. as of Q2 2016.

Based on Tudor Investment Corp's 13F filing for Q2 2016, filed 15 Aug 2016.